Company Financials

BELLUS Health Inc. Financials

Canadian dollar

business BELLUS Health Inc. Company Profile

Main Stock Listing

TSX: BLU

Market Capitalization C$2.47 Billion as of June 1, 2023

Market Cap History

Valuations Metrics as of Jan. 25, 2025

Trailing PE -29.56
Forward PE -15.58
Price to Sales TTM C$154631.38
Price to Book MRQ C$6.69
Enterprise to Revenue 149258.45
Enterprise to EBITDA -32.82

Financial Reports as of Mar. 31, 2023

Financials

Fiscal Year Ends 2022-12-31
Most Recent Quarter 2023-03-31
Profit Margin %
Operating Margin -474637.50%
Return on Assets TTM -18.66%
Return on Equity TTM -19.46%

Income Statement

Revenue TTM C$16,000
Revenue per Share TTM C$0.00
Quarterly Revenue Growth -25.00%
Gross Profit TTM C$0
EBITDA C$0
Net Income to Common TTM C$-76,080,000
Diluted EPS TTM C$-0.66
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ C$8,581,000
Total Cash per Share MRQ C$0.07
Total Debt MRQ C$
Total Debt to Equity MRQ 0.00
Current Ratio MRQ 33.42
Book Value per Share MRQ C$2.91

Cash Flow

Operating Cash Flow TTM C$-67,927,000
Levered Free Cash Flow TTM C$-76,080,000

BLU Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding 126,812,000
Float Shares None
Avg 10 Volume 113,584
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders %
% Held by Institutions %

Stock Price Summary

Beta
Fifty Two Week Low C$0.00
Fifty Two Week High C$0.00
Fifty Two Week Change %
Day 50 MA C$0.00
Day 200 MA C$0.00

Dividends and Splits

Forward Annual Dividend Rate C$
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate C$
Trailing Annual Dividend Yield %
Payout Ratio %
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2019-08-19